×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Juvenile Animal Studies and Pediatric Nonclinical Development
Session Chair(s)
Dinah Duarte, MSc
Signal Management Lead
European Medicines Agency, Netherlands
Juvenile Animal Studies and Pediatric Nonclinical Development: EU Perspective
Learning Objective : Discuss the importance of nonclinical juvenile animal guidance in pediatric drug development; Share real world experience from available historical data on juvenile animal studies; Examine if juvenile animal studies in nonclinical support for pediatric drug development has significantly changed.
Speaker(s)
Juvenile Animal Studies and Pediatric Nonclinical Development: EU Perspective
Dinah Duarte, MSc
European Medicines Agency, Netherlands
Signal Management Lead
Juvenile Animal Studies and Pediatric Nonclinical Development: Industry Perspective
Mark E Hurtt, PhD
Pfizer Inc, United States
Executive Director and Global Head, DSRD Centers of Emphasis
Have an account?